Metabolism and Pharmacokinetic Drug–Drug Interaction Profile of Vericiguat, A Soluble Guanylate Cyclase Stimulator: Results From Preclinical and Phase I Healthy Volunteer Studies

por Boettcher, Michael, Gerisch, Michael, Lobmeyer, Maximilian, Besche, Nina, Thomas, Dirk, Gerrits, Mireille, Lemmen, Julia, Mueck, Wolfgang, Radtke, Martin, Becker, Corina
Publicado 2020

Vericiguat in Combination with Short‐Acting Nitroglycerin in Patients With Chronic Coronary Syndromes: The Randomized, Phase Ib, VENICE Study

por Boettcher, Michael, Düngen, Hans‐Dirk, Donath, Frank, Mikus, Gerd, Werner, Nikos, Thuermann, Petra A., Karakas, Mahir, Besche, Nina, Koch, Tanja, Gurniak, Matthias, Becker, Corina
Publicado 2022

Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: The randomized, phase Ib, VISOR study

por Boettcher, Michael, Mikus, Gerd, Trenk, Dietmar, Düngen, Hans‐Dirk, Donath, Frank, Werner, Nikos, Karakas, Mahir, Besche, Nina, Schulz‐Burck, Dominik, Gerrits, Mireille, Hung, James, Becker, Corina
Publicado 2022

Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes

por Böttcher, Michael, Düngen, Hans-Dirk, Corcea, Vasile, Donath, Frank, Fuhr, Rainard, Gal, Pim, Mikus, Gerd, Trenk, Dietmar, Coenen, Martin, Pires, Philippe Vieira, Maschke, Claudia, Aliprantis, Antonios Othon, Besche, Nina, Becker, Corina
Publicado 2023